drugset / Trial / NCT01001208
The Efficacy and Safety of Adding Methotrexate to Etanercept in Psoriasis
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy of adding methotrexate to etanercept compared with etanercept monotherapy as measured by the percentage of participants achieving a 75% improvement from baseline in the Psoriasis Area and Severity Index (PASI 75) at Week 24.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-12
- Completion
- 2011-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etanercept | Protein / enzyme biologic | 50 mg | Subcutaneous |
| Subject | Methotrexate | Small molecule | 15 mg | — |